Global Canine Stem Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Canine Stem Cell Therapy estimated at US$ 106 million in the year 2022, is projected to reach a revised size of US$ 122.3 million by 2028, growing at a CAGR of 2.4% during the forecast period 2022-2028.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Canine Stem Cell Therapy companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Canine Stem Cell Therapy market. Further, it explains the major drivers and regional dynamics of the global Canine Stem Cell Therapy market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

VETSTEM BIOPHARMA

Cell Therapy Sciences

Regeneus

Aratana Therapeutics

Medivet Biologics

Okyanos

Vetbiologics

VetMatrix

Magellan Stem Cells

ANIMAL CELL THERAPIES

Stemcellvet

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Allogeneic Stem Cells

Autologous Stem cells

Veterinary Hospitals

Veterinary Clinics

Veterinary Research Institutes

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Canine Stem Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Canine Stem Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Canine Stem Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Canine Stem Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Canine Stem Cell Therapy revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Canine Stem Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Canine Stem Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix and Magellan Stem Cells, etc.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Canine Stem Cell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Allogeneic Stem Cells

1.2.3 Autologous Stem cells

1.3 Market by Application

1.3.1 Global Canine Stem Cell Therapy Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Veterinary Hospitals

1.3.3 Veterinary Clinics

1.3.4 Veterinary Research Institutes

1.4 Study Objectives

1.5 Years Considered

2.1 Global Canine Stem Cell Therapy Market Size (2017-2028)

2.2 Canine Stem Cell Therapy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Canine Stem Cell Therapy Market Size by Region (2017-2022)

2.4 Global Canine Stem Cell Therapy Market Size Forecast by Region (2023-2028)

2.5 Global Top Canine Stem Cell Therapy Countries Ranking by Market Size

3.1 Global Canine Stem Cell Therapy Revenue by Players

3.1.1 Global Canine Stem Cell Therapy Revenue by Players (2017-2022)

3.1.2 Global Canine Stem Cell Therapy Market Share by Players (2017-2022)

3.2 Global Canine Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Canine Stem Cell Therapy Revenue

3.4 Global Canine Stem Cell Therapy Market Concentration Ratio

3.4.1 Global Canine Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Canine Stem Cell Therapy Revenue in 2021

3.5 Global Canine Stem Cell Therapy Key Players Head office and Area Served

3.6 Key Players Canine Stem Cell Therapy Product Solution and Service

3.7 Date of Enter into Canine Stem Cell Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Canine Stem Cell Therapy Historic Revenue by Type (2017-2022)

4.2 Global Canine Stem Cell Therapy Forecasted Revenue by Type (2023-2028)

5.1 Global Canine Stem Cell Therapy Historic Market Size by Application (2017-2022)

5.2 Global Canine Stem Cell Therapy Forecasted Market Size by Application (2023-2028)

6.1 North America Canine Stem Cell Therapy Revenue by Company (2020-2022)

6.2 North America Canine Stem Cell Therapy Revenue by Type (2017-2028)

6.3 North America Canine Stem Cell Therapy Revenue by Application (2017-2028)

6.4 North America Canine Stem Cell Therapy Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7.1 Europe Canine Stem Cell Therapy Revenue by Company (2020-2022)

7.2 Europe Canine Stem Cell Therapy Revenue by Type (2017-2028)

7.3 Europe Canine Stem Cell Therapy Revenue by Application (2017-2028)

7.4 Europe Canine Stem Cell Therapy Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8.1 Asia Pacific Canine Stem Cell Therapy Revenue by Company (2020-2022)

8.2 Asia Pacific Canine Stem Cell Therapy Revenue by Type (2017-2028)

8.3 Asia Pacific Canine Stem Cell Therapy Revenue by Application (2017-2028)

8.4 Asia Pacific Canine Stem Cell Therapy Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9.1 Latin America Canine Stem Cell Therapy Revenue by Company (2020-2022)

9.2 Latin America Canine Stem Cell Therapy Revenue by Type (2017-2028)

9.3 Latin America Canine Stem Cell Therapy Revenue by Application (2017-2028)

9.4 Latin America Canine Stem Cell Therapy Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10.1 Middle East and Africa Canine Stem Cell Therapy Revenue by Company (2020-2022)

10.2 Middle East and Africa Canine Stem Cell Therapy Revenue by Type (2017-2028)

10.3 Middle East and Africa Canine Stem Cell Therapy Revenue by Application (2017-2028)

10.4 Middle East and Africa Canine Stem Cell Therapy Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 U.A.E

11.1 VETSTEM BIOPHARMA

11.1.1 VETSTEM BIOPHARMA Company Details

11.1.2 VETSTEM BIOPHARMA Business Overview

11.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Products and Services

11.1.4 VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.1.5 VETSTEM BIOPHARMA Canine Stem Cell Therapy SWOT Analysis

11.1.6 VETSTEM BIOPHARMA Recent Developments

11.2 Cell Therapy Sciences

11.2.1 Cell Therapy Sciences Company Details

11.2.2 Cell Therapy Sciences Business Overview

11.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Products and Services

11.2.4 Cell Therapy Sciences Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.2.5 Cell Therapy Sciences Canine Stem Cell Therapy SWOT Analysis

11.2.6 Cell Therapy Sciences Recent Developments

11.3 Regeneus

11.3.1 Regeneus Company Details

11.3.2 Regeneus Business Overview

11.3.3 Regeneus Canine Stem Cell Therapy Products and Services

11.3.4 Regeneus Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.3.5 Regeneus Canine Stem Cell Therapy SWOT Analysis

11.3.6 Regeneus Recent Developments

11.4 Aratana Therapeutics

11.4.1 Aratana Therapeutics Company Details

11.4.2 Aratana Therapeutics Business Overview

11.4.3 Aratana Therapeutics Canine Stem Cell Therapy Products and Services

11.4.4 Aratana Therapeutics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.4.5 Aratana Therapeutics Canine Stem Cell Therapy SWOT Analysis

11.4.6 Aratana Therapeutics Recent Developments

11.5 Medivet Biologics

11.5.1 Medivet Biologics Company Details

11.5.2 Medivet Biologics Business Overview

11.5.3 Medivet Biologics Canine Stem Cell Therapy Products and Services

11.5.4 Medivet Biologics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.5.5 Medivet Biologics Canine Stem Cell Therapy SWOT Analysis

11.5.6 Medivet Biologics Recent Developments

11.6 Okyanos

11.6.1 Okyanos Company Details

11.6.2 Okyanos Business Overview

11.6.3 Okyanos Canine Stem Cell Therapy Products and Services

11.6.4 Okyanos Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.6.5 Okyanos Canine Stem Cell Therapy SWOT Analysis

11.6.6 Okyanos Recent Developments

11.7 Vetbiologics

11.7.1 Vetbiologics Company Details

11.7.2 Vetbiologics Business Overview

11.7.3 Vetbiologics Canine Stem Cell Therapy Products and Services

11.7.4 Vetbiologics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.7.5 Vetbiologics Canine Stem Cell Therapy SWOT Analysis

11.7.6 Vetbiologics Recent Developments

11.8 VetMatrix

11.8.1 VetMatrix Company Details

11.8.2 VetMatrix Business Overview

11.8.3 VetMatrix Canine Stem Cell Therapy Products and Services

11.8.4 VetMatrix Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.8.5 VetMatrix Canine Stem Cell Therapy SWOT Analysis

11.8.6 VetMatrix Recent Developments

11.9 Magellan Stem Cells

11.9.1 Magellan Stem Cells Company Details

11.9.2 Magellan Stem Cells Business Overview

11.9.3 Magellan Stem Cells Canine Stem Cell Therapy Products and Services

11.9.4 Magellan Stem Cells Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.9.5 Magellan Stem Cells Canine Stem Cell Therapy SWOT Analysis

11.9.6 Magellan Stem Cells Recent Developments

11.10 ANIMAL CELL THERAPIES

11.10.1 ANIMAL CELL THERAPIES Company Details

11.10.2 ANIMAL CELL THERAPIES Business Overview

11.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Products and Services

11.10.4 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.10.5 ANIMAL CELL THERAPIES Canine Stem Cell Therapy SWOT Analysis

11.10.6 ANIMAL CELL THERAPIES Recent Developments

11.11 Stemcellvet

11.11.1 Stemcellvet Company Details

11.11.2 Stemcellvet Business Overview

11.11.3 Stemcellvet Canine Stem Cell Therapy Products and Services

11.11.4 Stemcellvet Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022)

11.11.5 Stemcellvet Recent Developments

12.1 Canine Stem Cell Therapy Market Trends

12.2 Canine Stem Cell Therapy Market Drivers

12.3 Canine Stem Cell Therapy Market Challenges

12.4 Canine Stem Cell Therapy Market Restraints

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

List of Tables

    Table 1. Global Canine Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Allogeneic Stem Cells

    Table 3. Key Players of Autologous Stem cells

    Table 4. Global Canine Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 5. Global Canine Stem Cell Therapy Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

    Table 6. Global Canine Stem Cell Therapy Revenue by Region (2017-2022) & (US$ Million)

    Table 7. Global Canine Stem Cell Therapy Revenue Market Share by Region (2017-2022)

    Table 8. Global Canine Stem Cell Therapy Revenue by Players (2017-2022) & (US$ Million)

    Table 9. Global Canine Stem Cell Therapy Market Share by Players (2017-2022)

    Table 10. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Stem Cell Therapy as of 2021)

    Table 11. Ranking of Global Top Canine Stem Cell Therapy Companies by Revenue (US$ Million) in 2021

    Table 12. Global 5 Largest Players Market Share by Canine Stem Cell Therapy Revenue (CR5 and HHI) & (2017-2022)

    Table 13. Key Players Headquarters and Area Served

    Table 14. Key Players Canine Stem Cell Therapy Product Solution and Service

    Table 15. Date of Key Manufacturers Enter into Canine Stem Cell Therapy Market

    Table 16. Mergers & Acquisitions, Expansion Plans

    Table 17. Global Canine Stem Cell Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 18. Global Canine Stem Cell Therapy Revenue Market Share by Type (2017-2022)

    Table 19. Global Canine Stem Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 20. Global Canine Stem Cell Therapy Revenue Market Share by Type (2023-2028)

    Table 21. Global Canine Stem Cell Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 22. Global Canine Stem Cell Therapy Revenue Market Share by Application (2017-2022)

    Table 23. Global Canine Stem Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 24. Global Canine Stem Cell Therapy Revenue Market Share by Application (2023-2028)

    Table 25. North America Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)

    Table 26. North America Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 27. North America Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)

    Table 28. North America Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 29. North America Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)

    Table 30. North America Canine Stem Cell Therapy Revenue by Country (2017-2022) & (US$ Million)

    Table 31. North America Canine Stem Cell Therapy Revenue by Country (2023-2028) & (US$ Million)

    Table 32. Europe Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)

    Table 33. Europe Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 34. Europe Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)

    Table 35. Europe Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 36. Europe Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)

    Table 37. Europe Canine Stem Cell Therapy Revenue by Country (2017-2022) & (US$ Million)

    Table 38. Europe Canine Stem Cell Therapy Revenue by Country (2023-2028) & (US$ Million)

    Table 39. Asia Pacific Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)

    Table 40. Asia Pacific Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 41. Asia Pacific Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)

    Table 42. Asia Pacific Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 43. Asia Pacific Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)

    Table 44. Asia Pacific Canine Stem Cell Therapy Revenue by Region (2017-2022) & (US$ Million)

    Table 45. Asia Pacific Canine Stem Cell Therapy Revenue by Region (2023-2028) & (US$ Million)

    Table 46. Latin America Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)

    Table 47. Latin America Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 48. Latin America Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)

    Table 49. Latin America Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 50. Latin America Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)

    Table 51. Latin America Canine Stem Cell Therapy Revenue by Country (2017-2022) & (US$ Million)

    Table 52. Latin America Canine Stem Cell Therapy Revenue by Country (2023-2028) & (US$ Million)

    Table 53. Middle East and Africa Canine Stem Cell Therapy Revenue by Company (2020-2022) & (US$ Million)

    Table 54. Middle East and Africa Canine Stem Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 55. Middle East and Africa Canine Stem Cell Therapy Revenue by Type (2023-2028) & (US$ Million)

    Table 56. Middle East and Africa Canine Stem Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 57. Middle East and Africa Canine Stem Cell Therapy Revenue by Application (2023-2028) & (US$ Million)

    Table 58. Middle East and Africa Canine Stem Cell Therapy Revenue by Country (2017-2022) & (US$ Million)

    Table 59. Middle East and Africa Canine Stem Cell Therapy Revenue by Country (2023-2028) & (US$ Million)

    Table 60. VETSTEM BIOPHARMA Company Details

    Table 61. VETSTEM BIOPHARMA Business Overview

    Table 62. VETSTEM BIOPHARMA Canine Stem Cell Therapy Product and Services

    Table 63. VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 64. VETSTEM BIOPHARMA Canine Stem Cell Therapy SWOT Analysis

    Table 65. VETSTEM BIOPHARMA Recent Developments

    Table 66. Cell Therapy Sciences Company Details

    Table 67. Cell Therapy Sciences Business Overview

    Table 68. Cell Therapy Sciences Canine Stem Cell Therapy Product and Services

    Table 69. Cell Therapy Sciences Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 70. Cell Therapy Sciences Canine Stem Cell Therapy SWOT Analysis

    Table 71. Cell Therapy Sciences Recent Developments

    Table 72. Regeneus Company Details

    Table 73. Regeneus Business Overview

    Table 74. Regeneus Canine Stem Cell Therapy Product and Services

    Table 75. Regeneus Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 76. Regeneus Canine Stem Cell Therapy SWOT Analysis

    Table 77. Regeneus Recent Developments

    Table 78. Aratana Therapeutics Company Details

    Table 79. Aratana Therapeutics Business Overview

    Table 80. Aratana Therapeutics Canine Stem Cell Therapy Product and Services

    Table 81. Aratana Therapeutics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 82. Aratana Therapeutics Canine Stem Cell Therapy SWOT Analysis

    Table 83. Aratana Therapeutics Recent Developments

    Table 84. Medivet Biologics Company Details

    Table 85. Medivet Biologics Business Overview

    Table 86. Medivet Biologics Canine Stem Cell Therapy Product and Services

    Table 87. Medivet Biologics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 88. Medivet Biologics Canine Stem Cell Therapy SWOT Analysis

    Table 89. Medivet Biologics Recent Developments

    Table 90. Okyanos Company Details

    Table 91. Okyanos Business Overview

    Table 92. Okyanos Canine Stem Cell Therapy Product and Services

    Table 93. Okyanos Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 94. Okyanos Canine Stem Cell Therapy SWOT Analysis

    Table 95. Okyanos Recent Developments

    Table 96. Vetbiologics Company Details

    Table 97. Vetbiologics Business Overview

    Table 98. Vetbiologics Canine Stem Cell Therapy Product and Services

    Table 99. Vetbiologics Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 100. Vetbiologics Canine Stem Cell Therapy SWOT Analysis

    Table 101. Vetbiologics Recent Developments

    Table 102. VetMatrix Company Details

    Table 103. VetMatrix Business Overview

    Table 104. VetMatrix Canine Stem Cell Therapy Product and Services

    Table 105. VetMatrix Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 106. VetMatrix Canine Stem Cell Therapy SWOT Analysis

    Table 107. VetMatrix Recent Developments

    Table 108. Magellan Stem Cells Company Details

    Table 109. Magellan Stem Cells Business Overview

    Table 110. Magellan Stem Cells Canine Stem Cell Therapy Product and Services

    Table 111. Magellan Stem Cells Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 112. Magellan Stem Cells Canine Stem Cell Therapy SWOT Analysis

    Table 113. Magellan Stem Cells Recent Developments

    Table 114. ANIMAL CELL THERAPIES Company Details

    Table 115. ANIMAL CELL THERAPIES Business Overview

    Table 116. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product and Services

    Table 117. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 118. ANIMAL CELL THERAPIES Canine Stem Cell Therapy SWOT Analysis

    Table 119. ANIMAL CELL THERAPIES Recent Developments

    Table 120. Stemcellvet Company Details

    Table 121. Stemcellvet Business Overview

    Table 122. Stemcellvet Canine Stem Cell Therapy Product and Services

    Table 123. Stemcellvet Canine Stem Cell Therapy Revenue in Canine Stem Cell Therapy Business (2017-2022) & (US$ Million)

    Table 124. Stemcellvet Recent Developments

    Table 125. Canine Stem Cell Therapy Market Trends

    Table 126. Canine Stem Cell Therapy Market Drivers

    Table 127. Canine Stem Cell Therapy Market Challenges

    Table 128. Canine Stem Cell Therapy Market Restraints

    Table 129. Research Programs/Design for This Report

    Table 130. Key Data Information from Secondary Sources

    Table 131. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Canine Stem Cell Therapy Sales Market Share by Type: 2021 VS 2028

    Figure 2. Allogeneic Stem Cells Features

    Figure 3. Autologous Stem cells Features

    Figure 4. Global Canine Stem Cell Therapy Sales Market Share by Application: 2021 VS 2028

    Figure 5. Veterinary Hospitals Case Studies

    Figure 6. Veterinary Clinics Case Studies

    Figure 7. Veterinary Research Institutes Case Studies

    Figure 8. Canine Stem Cell Therapy Report Years Considered

    Figure 9. Global Canine Stem Cell Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 10. Global Canine Stem Cell Therapy Market Size 2017-2028 (US$ Million)

    Figure 11. Global Canine Stem Cell Therapy Market Size Market Share by Region: 2021 VS 2028

    Figure 12. Global Canine Stem Cell Therapy Revenue Market Share by Region in 2017 VS 2022

    Figure 13. Global Top 10 Canine Stem Cell Therapy Countries Ranking by Market Size (US$ Million) in 2021

    Figure 14. Global Canine Stem Cell Therapy Market Share by Players in 2021

    Figure 15. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Stem Cell Therapy as of 2021)

    Figure 16. The Top 10 and 5 Players Market Share by Canine Stem Cell Therapy Revenue in 2021

    Figure 17. North America Canine Stem Cell Therapy Revenue Market Share by Company in 2021

    Figure 18. North America Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)

    Figure 19. North America Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)

    Figure 20. North America Canine Stem Cell Therapy Revenue Share by Country (2017-2028)

    Figure 21. U.S. Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 22. Canada Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 23. Europe Canine Stem Cell Therapy Revenue Market Share by Company in 2021

    Figure 24. Europe Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)

    Figure 25. Europe Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)

    Figure 26. Europe Canine Stem Cell Therapy Revenue Share by Country (2017-2028)

    Figure 27. Germany Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 28. France Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 29. U.K. Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 30. Italy Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 31. Russia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 32. Asia Pacific Canine Stem Cell Therapy Revenue Market Share by Company in 2021

    Figure 33. Asia Pacific Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)

    Figure 34. Asia Pacific Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)

    Figure 35. Asia Pacific Canine Stem Cell Therapy Revenue Share by Region (2017-2028)

    Figure 36. China Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 37. Japan Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 38. South Korea Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 39. India Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 40. Australia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 41. Taiwan Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 42. Indonesia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 43. Thailand Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 44. Malaysia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 45. Philippines Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 46. Vietnam Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 47. Latin America Canine Stem Cell Therapy Revenue Market Share by Company in 2021

    Figure 48. Latin America Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)

    Figure 49. Latin America Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)

    Figure 50. Latin America Canine Stem Cell Therapy Revenue Share by Country (2017-2028)

    Figure 51. Mexico Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 52. Brazil Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 53. Argentina Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 54. Middle East and Africa Canine Stem Cell Therapy Revenue Market Share by Company in 2021

    Figure 55. Middle East and Africa Canine Stem Cell Therapy Revenue Market Share by Type (2017-2028)

    Figure 56. Middle East and Africa Canine Stem Cell Therapy Revenue Market Share by Application (2017-2028)

    Figure 57. Middle East and Africa Canine Stem Cell Therapy Revenue Share by Country (2017-2028)

    Figure 58. Turkey Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 59. Saudi Arabia Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 60. U.A.E Canine Stem Cell Therapy Revenue (2017-2028) & (US$ Million)

    Figure 61. VETSTEM BIOPHARMA Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 62. Cell Therapy Sciences Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 63. Regeneus Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 64. Aratana Therapeutics Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 65. Medivet Biologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 66. Okyanos Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 67. Vetbiologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 68. VetMatrix Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 69. Magellan Stem Cells Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 70. ANIMAL CELL THERAPIES Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 71. Stemcellvet Revenue Growth Rate in Canine Stem Cell Therapy Business (2017-2022)

    Figure 72. Bottom-up and Top-down Approaches for This Report

    Figure 73. Data Triangulation

    Figure 74. Key Executives Interviewed